Matt Zuga
CFO & Chief Business OfficerMr. William Matthew Zuga, also known as Matt, is CFO & Chief Business Officer of Acumen Pharmaceuticals, Inc. He was CFO, Chief Business Officer & Corporate Secretary of Acumen Pharmaceuticals, Inc. He was CFO & Chief Business Officer of Acumen Pharmaceuticals, Inc. from May 2021. He is Managing Director and Managing Partner of Red Abbey Venture Partners, LLC. He is Founder of HighCape Partners Management, L.P. He is Director of AgriMetis LLC. He is CFO, COO & Director of Highcape Capital Acquisition Corp. II from February 2021. He was Member of Advisory Board of Capital A Partners. He was Investment Advisor of New Markets Venture Partners. He was Board Observer of Shire Regenerative Medicine, Inc. He was Independent Director of TELA Bio, Inc. from May 2019 to April 20, 2020. He was employed at TELA Bio, Inc. until April 20, 2020. He was Co-Chairman of Alba Therapeutics Corporation. He was Board Observer of Sirtris Pharmaceuticals, Inc. He was Director of Population Genetics Technologies Ltd. He was Director of Corridor Pharmaceuticals, Inc. He was Independent Director of Elutia Inc. until October 2025. He was Non-Independent Director of Elutia Inc. from November 2015. He was employed at Elutia Inc. from November 2015 to October 2025. He was CFO, COO & Director of HighCape Capital Acquisition Corp. from June 2020. He has B.S.B.A. in Finance from The Ohio State University in 1988, M.B.A. from Kenan-Flagler Business School in 1993.
Positions
- Company NameAcumen Pharmaceuticals, Inc.Stock CodeABOSPositionCFO & Chief Business OfficerColleagues
- DJDaniel J. O'ConnellCEO & Director
- GSGeorge S. GolumbeskiIndependent Chairman of the Board
- JDJames DohertyPresident & Chief Development Officer
- GAGrant A. KrafftCo-Founder
- CECaleb E. FinchCo-Founder
- JLJeffrey L. C. IvesIndependent Director
- LSLaura StoppelIndependent Director
- KCKimberlee Cobleigh DrapkinIndependent Director
